At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Test Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study
In Brief
A clinical study evaluating Test Lens and Control Lens for Visual Acuity. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This will be a split-plot design, randomized, parallel, double-masked feasibility study to evaluate the role of a test lens on contrast sensitivity with and without glare.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedOct 2022
Enrollment StartOct 2022
Primary CompletionDec 2022
TodayJul 2026
First PostedOct 17, 2022
Enrollment StartOct 31, 2022
Primary CompletionDec 8, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.7 years ago
Interventions
Test Lensdevice
ACUVUE OASYS MAX 1-Day with TearStable Technology and OptiBlue Light Filter
Control Lensdevice
ACUVUE OASYS 1-Day with HydraLuxe Technology